[Comparison on clinical features between dilated cardiomyopathy patients with or without pulmonary hypertension]

Wei-hua Zhang1, Hui Xu, Yang Zheng

  • 1Cardiovascular Diseases Center, First Hospital of Jilin University, Changchun , China.

Insights

Pulmonary hypertension (PH) in dilated cardiomyopathy (DCM) patients is associated with more severe clinical features. DCM patients with PH showed worse heart function and higher bilirubin levels compared to those without PH.

Area of Science:

  • Cardiology
  • Pulmonary Medicine
  • Medical Diagnostics

Background:

  • Dilated cardiomyopathy (DCM) is a significant cause of heart failure.
  • Pulmonary hypertension (PH) can be a complication of DCM, affecting prognosis.
  • Echocardiography is crucial for diagnosing DCM and assessing cardiac function.

Purpose of the Study:

  • To compare clinical data of DCM patients with and without pulmonary hypertension (PH).
  • To identify echocardiographic and clinical differences between DCM with PH and DCM without PH.

Main Methods:

  • Retrospective analysis of 112 DCM patients (61 with PH, 51 without PH) from January 2007 to December 2009.
  • Comparison of demographic, clinical, echocardiographic, and serum biomarker data.
  • Echocardiography was used for PH diagnosis and cardiac function assessment.

Main Results:

  • Patients with DCM and PH exhibited higher rates of NYHA class III/IV, larger left atrial and left ventricle dimensions, and increased right ventricular outflow tract dimensions.
  • DCM with PH group showed a higher incidence of pericardial effusion and elevated serum total bilirubin levels.
  • Ejective fraction was significantly lower in DCM patients with PH compared to those without PH, indicating poorer heart function.

Conclusions:

  • Pulmonary hypertension is associated with more severe clinical manifestations in dilated cardiomyopathy.
  • DCM patients with PH present with worse cardiac function and elevated bilirubin levels.
  • These findings highlight the clinical impact of PH on DCM progression and severity.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...